{"schemaVersion":"peptidescanner-peptide-evidence-feed/v1","canonicalUrl":"https://peptidescanner.com/feeds/peptides/cibinetide.json","peptide":{"slug":"cibinetide","name":"Cibinetide","url":"https://peptidescanner.com/peptides/cibinetide/"},"release":{"label":"Beta · 17 Nov 2026","reviewedAt":"2026-11-17"},"entryCount":4,"entries":[{"objectId":"story:clinicaltrials-gov-nct02039687-cibinetide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT02039687","domain":"Clinical trials","dateInSource":"2017-04-18","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02039687-cibinetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cibinetide.json#clinicaltrials-gov-nct02039687-cibinetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cibinetide.md#clinicaltrials-gov-nct02039687-cibinetide-v1","contentSha256":"65b5847a30288ff143f4dac88b633c552523dbb59035f7c708eb082133bad555"},{"objectId":"story:pubmed-pmid-24555851-cibinetide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ARA 290 for treatment of small fiber neuropathy in sarcoidosis.","domain":"Literature metadata","dateInSource":"2018-05-25","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-24555851-cibinetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cibinetide.json#pubmed-pmid-24555851-cibinetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cibinetide.md#pubmed-pmid-24555851-cibinetide-v1","contentSha256":"8410da16d1d505d0a70519b4ba5831b5344d62ab23a59b07539ed88fd864e476"},{"objectId":"story:pubmed-pmid-26774587-cibinetide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ARA 290 relieves pathophysiological pain by targeting TRPV1 channel: Integration between immune system and nociception.","domain":"Literature metadata","dateInSource":"2018-05-25","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-26774587-cibinetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cibinetide.json#pubmed-pmid-26774587-cibinetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cibinetide.md#pubmed-pmid-26774587-cibinetide-v1","contentSha256":"ce0dba8db058137c1e4f1f9cb3c0bc622f836fcd63a8c56052c29c00b545d83a"},{"objectId":"story:pubmed-pmid-32674280-cibinetide:v1","state":"current","stateChangedAt":"2026-11-16","title":"A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema.","domain":"Literature metadata","dateInSource":"2020-09-28","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-32674280-cibinetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/cibinetide.json#pubmed-pmid-32674280-cibinetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/cibinetide.md#pubmed-pmid-32674280-cibinetide-v1","contentSha256":"55779b55e20a708055f254d658c2b4e05d152abc7e8d372686a8b491f3493644"}]}
